Local Time
English (UK) Deutsch (DE) Français (FR) Español (ES) Italian (IT)
Scythian Aims to Acquire Argentinian Company
Author: Bryan Mc Govern 12/03/2018 - 15:36:00

Scythian Biosciences (TSXV:SCYB; OTC:SCCYF) announced a non-binding letter of intent with MMJ International Investments to acquire the company. 

As quoted in the press release:

MMJ is the owner of an Argentina-based corporation, ABP S.A. (“ABP”). ABP is a pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical products and derivatives in Argentina.

“Scythian is expanding its reach into Argentina under the auspices of one of the nation’s leading importers and distributors of pharmaceuticals,” said Vic Neufeld, a director of Scythian and current CEO of global cannabis leader Aphria Inc. (“Aphria”). “This is an exciting opportunity for Scythian as it continues to evaluate a number of other strategic initiatives intended to grow the Company’s business.”

The Proposed Acquisition complements Scythian’s existing cannabinoid-based drug development program and aligns with the Company’s long-term strategy to enhance the medical applications of cannabis. It will give Scythian access to Argentina’s network of hospitals, doctors, retail pharmacies, private health providers and public health system and will advance the Company’s objective to provide patients with access to safe, pharmaceutical-grade medical cannabis.

Click here to read the full press release.

The post Scythian Aims to Acquire Argentinian Company appeared first on Investing News Network.

Original article: Scythian Aims to Acquire Argentinian Company


Total pages / language:   30'256 / 18'921
In the archive :   46'558
Pages last 24 hours:   29
This Month Pages:   994
Views:   8'649'200553'481
Views Archive:   11'171'243

©2018 - Hempyreum.org - News aggregator about Hemp and Cannabis [Beta] | All rights and ownership of the contents belong to their respective holders